Difficulty: Medium
Average Score: 87%
Practice
A 72-year-old man is brought to his physician by his son. The son complains that this patient has been becoming forgetful, confused, moody, and aggressive over the past few months. Which of the following neurotransmitter changes is characteristic of Alzheimer's disease?
Correct answer
A
Rationale
In Alzheimer's disease, there is a characteristic decrease in acetylcholine levels. Acetylcholine is a neurotransmitter that plays a crucial role in memory, learning, and cognitive functions. The decline in acetylcholine levels contributes to the cognitive decline seen in Alzheimer's patients.
Option A, decreased acetylcholine, is correct because it aligns with the pathophysiology of Alzheimer's disease. The decrease in acetylcholine levels leads to impaired neurotransmission and contributes to the cognitive symptoms observed in this condition.
Options B and C, decreased dopamine and norepinephrine, are not characteristic neurotransmitter changes in Alzheimer's disease. While dopamine and norepinephrine are involved in various brain functions, their decrease is not specifically linked to Alzheimer's pathology.
Option D, increased acetylcholine, is also incorrect. In Alzheimer's disease, there is a decrease, not an increase, in acetylcholine levels.
Understanding the neurotransmitter changes in Alzheimer's disease is crucial for healthcare professionals in diagnosing and managing patients with this condition. Recognizing the specific neurotransmitter alterations can guide the selection of appropriate pharmacological interventions to help alleviate symptoms and improve patient outcomes.
Option A, decreased acetylcholine, is correct because it aligns with the pathophysiology of Alzheimer's disease. The decrease in acetylcholine levels leads to impaired neurotransmission and contributes to the cognitive symptoms observed in this condition.
Options B and C, decreased dopamine and norepinephrine, are not characteristic neurotransmitter changes in Alzheimer's disease. While dopamine and norepinephrine are involved in various brain functions, their decrease is not specifically linked to Alzheimer's pathology.
Option D, increased acetylcholine, is also incorrect. In Alzheimer's disease, there is a decrease, not an increase, in acetylcholine levels.
Understanding the neurotransmitter changes in Alzheimer's disease is crucial for healthcare professionals in diagnosing and managing patients with this condition. Recognizing the specific neurotransmitter alterations can guide the selection of appropriate pharmacological interventions to help alleviate symptoms and improve patient outcomes.